Plasma levels of ANP are increased in patients with heart failure caused by cardiac valve pathology, coronary heart disease, congenital heart defects, dilated and hypertrophic cardiomyopathies, and AF compared with control patients51–55. This evidence concerns the gene NPPA and atrial fibrillation.